Walgreens Boots Alliance (WBA) Stock Price, News & Analysis

Company Overview

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

Key Stats

• Today's Range: $11.58 to $11.64
• 50-Day Range: $11.17 to $11.61
• 52-Week Range: $8.08 to $13.25
• Volume: 4.79 million shs
• Average Volume: 6.07 million shs
• Market Capitalization: $10.05 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.59
• Consensus Rating: Reduce

Walgreens Boots Alliance Stock Analysis - MarketRank™

Walgreens Boots Alliance scored higher than 41% of companies evaluated by MarketBeat, and ranked 167th out of 212 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.9 / 5
• Analyst Rating: Reduce

Consensus Rating

Walgreens Boots Alliance has received a consensus rating of Reduce. The company's average rating score is 1.83, and is based on 2 buy ratings, 6 hold ratings, and 4 sell ratings.

Amount of Analyst Coverage

Walgreens Boots Alliance has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: -8.75%

Earnings Growth

Earnings for Walgreens Boots Alliance are expected to decrease by -8.75% in the coming year, from $1.60 to $1.46 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Walgreens Boots Alliance is -1.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Walgreens Boots Alliance is -1.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Walgreens Boots Alliance has a PEG Ratio of 1.36. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Walgreens Boots Alliance has a P/B Ratio of 1.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.98% of the float of Walgreens Boots Alliance has been sold short.

Short Interest Ratio / Days to Cover

Walgreens Boots Alliance has a short interest ratio ("days to cover") of 11.7, which indicates bearish sentiment.

Change versus previous month

Short interest in Walgreens Boots Alliance has recently decreased by 18.66%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Walgreens Boots Alliance does not currently pay a dividend.

Dividend Growth

Walgreens Boots Alliance does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 2.3 / 5
• Environmental Score: -2.09

Percentage of Shares Shorted

9.98% of the float of Walgreens Boots Alliance has been sold short.

Short Interest Ratio / Days to Cover

Walgreens Boots Alliance has a short interest ratio ("days to cover") of 11.7, which indicates bearish sentiment.

Change versus previous month

Short interest in Walgreens Boots Alliance has recently decreased by 18.66%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 1.42

News Sentiment

Walgreens Boots Alliance has a news sentiment score of 1.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.92 average news sentiment score of Retail/Wholesale companies.

News Coverage This Week

MarketBeat has tracked 11 news articles for Walgreens Boots Alliance this week, compared to 29 articles on an average week.

Search Interest

27 people have searched for WBA on MarketBeat in the last 30 days. This is an increase of 4% compared to the previous 30 days.

MarketBeat Follows

Only 5 people have added Walgreens Boots Alliance to their MarketBeat watchlist in the last 30 days. This is a decrease of -38% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Walgreens Boots Alliance insiders have bought more of their company's stock than they have sold. Specifically, they have bought $9,163,161.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

17.50% of the stock of Walgreens Boots Alliance is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

58.59% of the stock of Walgreens Boots Alliance is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

WBA Stock Analysis - Frequently Asked Questions

How have WBA shares performed this year?

Walgreens Boots Alliance's stock was trading at $9.33 at the start of the year. Since then, WBA stock has increased by 24.4% and is now trading at $11.61.

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) issued its quarterly earnings results on Thursday, June, 26th. The pharmacy operator reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.04. The company's revenue was up 7.2% on a year-over-year basis.

Does Walgreens Boots Alliance have any subsidiaries?

Walgreens Boots Alliance subsidiaries include Shields Health Solutions, Innovation Associates Inc, Sinopharm Holding GuoDa Drug Store Co., Liz Earle Beauty, Take Care Health Employer Solutions, Alliance Boots Holdings Limited, Alliance Healthcare Deutschland AG, and more.

Who are Walgreens Boots Alliance's major shareholders?

Walgreens Boots Alliance's top institutional shareholders include Syquant Capital Sas (0.15%), Vontobel Holding Ltd. (0.14%), Thompson Investment Management Inc. (0.08%) and Kapitalo Investimentos Ltda (0.08%). Insiders that own company stock include Stefano Pessina, Timothy C Wentworth, Rosalind G Brewer, Manmohan Mahajan, Richard P Gates, John Patrick Driscoll, Kevin M Ban, Valerie B Jarrett, Inderpal S Bhandari and Nancy M Schlichting.
View institutional ownership trends.

How do I buy shares of Walgreens Boots Alliance?

Shares of WBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Walgreens Boots Alliance own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Walgreens Boots Alliance investors own include JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Symbotic (SYM), Verizon Communications (VZ), Meta Platforms (META), NVIDIA (NVDA), Intel (INTC) and Humana (HUM).

Company Calendar

• Last Earnings: 6/26/2025
• Today: 7/25/2025
• Fiscal Year End: 8/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Retail/Wholesale
• Industry: RETAIL - DRUG STR
• Sub-Industry: Drug Retail
• Current Symbol: NASDAQ:WBA
• CIK: 1618921
• Web: www.walgreensbootsalliance.com
• Phone: (847) 315-3700
• Fax: 847-914-2804
• Employees: 312,000
• Year Founded: 2014

Price Target and Rating

• Average Price Target for Walgreens Boots Alliance: $10.59
• High Price Target: $15.00
• Low Price Target: $7.00
• Potential Upside/Downside: -9.0%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.83
• Research Coverage: 12 Analysts

Profitability

• EPS (Trailing Twelve Months): ($7.29)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 7.27
• P/E Growth: 1.35
• Net Income: -$8.64 billion
• Net Margins: -4.07%
• Pretax Margin: -3.79%
• Return on Equity: 17.66%
• Return on Assets: 2.22%

Debt

• Debt-to-Equity Ratio: 0.96
• Current Ratio: 0.60
• Quick Ratio: 0.32

Sales & Book Value

• Annual Sales: $147.66 billion
• Price / Sales: 0.07
• Cash Flow: $5.79 per share
• Price / Cash Flow: 2.01
• Book Value: $8.33 per share
• Price / Book: 1.40

Miscellaneous

• Outstanding Shares: 865,560,000
• Free Float: 714,088,000
• Market Cap: $10.07 billion
• Optionable: Optionable
• Beta: 0.78